Do you have a firm grasp and understanding of what substantial equivalence means in regards to the 510(k)?

Many don’t understand it; the evidence is the large percentage of submissions that are rejected due to a lack of demonstrating substantial equivalence.

Today we’re talking with Mike Drues, President of Vascular Sciences about demonstrating substantial equivalence, so if you’re not rock-solid on the concept, you won’t want to miss this episode.

Some of the highlights of the show include:

●Exactly what substantial equivalence means as it applies to the regulatory process and why it’s important.
●Why it’s challenging to demonstrate substantial equivalence.
●Mike’s approach to evaluating and demonstrating substantial equivalence.
●Some of the common errors that Mike sees in submissions that pertain to substantial equivalence.
●What happens if you get it wrong in the eyes of the FDA.
●An explanation of product codes and how they relate to substantial equivalence.
●Examples of how you might demonstrate substantial equivalence between common objects - stressing their similarities while de-emphasizing their differences.